U.S. Healthcare Services Stock News

NYSE:BRO
NYSE:BROInsurance

Brown & Brown (BRO) Rebounds, But Is Its Valuation Story Already Priced In?

Brown & Brown (BRO) recently drew investor attention after a period of mixed returns, including a decline of 10.65% year to date. This has prompted closer scrutiny of its valuation and business fundamentals. See our latest analysis for Brown & Brown. Despite the year to date share price decline of 10.65% and a 1 year total shareholder return that is down 32.62%, Brown & Brown has recently seen momentum firming, with a 30 day share price return of 17.46% and a 7 day gain of 2.50% from a latest...
NasdaqGS:AXON
NasdaqGS:AXONAerospace & Defense

Axon Enterprise (AXON) Following Board Additions And A Fresh Undervalued Narrative

Board additions put governance in focus for Axon Enterprise Axon Enterprise (AXON) has drawn fresh attention after appointing Vivek Mohindra and Eiso Kant as independent directors, with Mohindra joining key board committees and Kant observing the M&A and capital structure committee. For investors watching Axon Enterprise stock, these appointments put board composition, oversight of financial reporting and future deal making in the spotlight rather than short term trading moves. See our latest...
NYSE:BLCO
NYSE:BLCOMedical Equipment

Bausch + Lomb (BLCO) Could Be 59% Undervalued On EyeGility Launch

Bausch + Lomb (BLCO) has drawn fresh attention after launching its EyeGility Inserter in the U.S., a preloaded intraocular lens delivery system for its enVista Aspire and upcoming Envy cataract lenses. See our latest analysis for Bausch + Lomb. Despite a 1-day share price return that declined 3.27% to around US$16.26 following the EyeGility news, Bausch + Lomb’s 30-day share price return of 9.42% and 1-year total shareholder return of 16.98% suggest improving momentum, even as the 3-year...
NasdaqGS:FIVE
NasdaqGS:FIVESpecialty Retail

Is Five Below’s (FIVE) 2,000th Store Milestone Reframing Its Community-Driven Growth Narrative?

Five Below recently marked a major milestone by celebrating the grand opening of its 2,000th store at 299 Commerce Avenue in LaGrange, Georgia, featuring giveaways, games and a limited-edition Neon Squishy Dumpling for the first 200 customers. The company’s partnership with several metro-Atlanta Boys & Girls Clubs underscores how its rapid store expansion is being paired with local community investment aimed at enhancing kid-focused spaces. We’ll now examine how this 2,000th store milestone,...
NasdaqGS:INTU
NasdaqGS:INTUSoftware

Is Intuit (INTU) Undervalued Following Its Lawsuit, Layoffs, And Weaker TurboTax Outlook?

Intuit (INTU) is back in focus after a new class action lawsuit, large scale layoffs, office closures, and softer TurboTax performance. These developments are prompting investors to reassess both its legal exposure and core tax business. See our latest analysis for Intuit. At a share price of $291.09, Intuit reflects a recent 7 day share price return of 5.87% and a 30 day share price return of 8.18%, but the 90 day share price return has fallen 25.98% and the 1 year total shareholder return...
NYSE:AESI
NYSE:AESIEnergy Services

Is Atlas Energy Solutions (AESI) Fully Valued On Its Shift To A $50.3 Million Loss?

Atlas Energy Solutions (AESI) recently moved from profitability to a net loss of about $50.3 million in fiscal 2025. This shift places its cost structure and future earnings path in sharper focus. See our latest analysis for Atlas Energy Solutions. Atlas Energy Solutions' share price has pulled back recently, with a 30 day share price return of down 12.5% and a 7 day share price return of down 2.2%. At the same time, the year to date share price return of 44.8% and 90 day share price return...
NasdaqGS:GEHC
NasdaqGS:GEHCMedical Equipment

Did GE HealthCare’s US$500 Million Catholic Health Alliance and Mayo Clinic Theranostics Push Just Shift GEHC’s Investment Narrative?

Catholic Health recently announced a past 10-year Care Alliance with GE HealthCare worth about US$500 million to modernize imaging, diagnostics, and AI-enabled technology across more than 40 sites and multiple clinical service lines. Alongside this, GE HealthCare’s new theranostics research collaboration with Mayo Clinic on personalized radioligand therapy underlines its push into advanced molecular imaging and precision oncology tools. We’ll now examine how the long-term Catholic Health...
NYSE:GWRE
NYSE:GWRESoftware

Is Germania Mutual’s AI Rollout Quietly Reinforcing Guidewire’s (GWRE) Core Cloud-and-Data Moat?

Germania Mutual Insurance Company recently deployed ProNavigator, Guidewire Software’s embedded AI assistant, across its underwriting and claims operations to give employees secure, instant access to company knowledge and context. This rollout exemplifies how insurers are starting to embed AI directly into core systems so staff can make faster, better-informed decisions on complex policies and claims. We’ll now explore how Germania Mutual’s adoption of Guidewire’s ProNavigator AI assistant...
NasdaqGM:HRMY
NasdaqGM:HRMYPharmaceuticals

Harmony Biosciences Holdings (HRMY) Is Down 8.3% After Reaffirming 2026 Guidance And CFO Transition - Has The Bull Case Changed?

Harmony Biosciences Holdings recently reported preliminary, unaudited Q2 2026 net product revenue of about US$261 million for WAKIX, reaffirming its full‑year 2026 net product revenue guidance of US$1.0 billion to US$1.04 billion. On the same day, the company disclosed a CFO change, with long‑time finance leader Stephen Mollichella stepping in as Interim Principal Financial Officer while Harmony maintains that its performance and momentum remain unaffected. We’ll now examine how reaffirmed...
NasdaqGS:AMSC
NasdaqGS:AMSCElectrical

American Superconductor (AMSC) Stock Looks Fairly Valued With Cheap Earnings But Rich Broader Checks

American Superconductor stock has delivered a very large 3 year return, yet the current valuation checks now point to a mixed picture rather than a clear bargain or clear overvaluation. Over the past 3 years, American Superconductor has returned about 3.5x an initial investment, which makes the recent pullback especially relevant for anyone reassessing the stock. Future revenue and cash flow expectations can support the current share price, but any disappointment in execution or timing may...
NYSE:EW
NYSE:EWMedical Equipment

Edwards Lifesciences (EW) Faces FTC Penalty, Is The Stock Still Cheap?

Regulatory shock puts Edwards Lifesciences stock under a sharper lens The Federal Trade Commission’s record $12 million penalty tied to Edwards Lifesciences (EW) acquisition of JC Medical, along with new restrictions on future TAVR AR deals, has pushed the stock’s regulatory risk profile into sharper focus. See our latest analysis for Edwards Lifesciences. Since the FTC action, Edwards Lifesciences’ recent 1 day share price return of 2.4% and 7 day return of 7.03% show selling pressure...
NasdaqGS:SMCI
NasdaqGS:SMCITech

Super Micro Computer (SMCI) Faces ITC Probe And Cooling Expansion, Is It Undervalued?

Super Micro Computer (SMCI) is in focus after US trade regulators opened an investigation into Samsung memory products used in its systems, while the company expanded its liquid cooling lineup for high density AI data centers. See our latest analysis for Super Micro Computer. Against this backdrop, Super Micro Computer’s share price has come under pressure, with the stock down 14.6% over the past week and 21.9% year to date. The 1 year total shareholder return has fallen 53.3%, suggesting...
NYSE:EXPD
NYSE:EXPDLogistics

Can Expeditors (EXPD) Turn Routing Agility Into a Lasting Edge as Freight Rates Rise?

Recently, Expeditors International of Washington attracted favorable attention as analysts raised earnings estimates and awarded it a strong Momentum Style Score and an improved Zacks Rank, citing resilient business performance. An interesting angle is how the company’s ability to adjust freight routing and pricing amid rising rates has reinforced confidence in its cash flow resilience. With this backdrop and Expeditors’ improved earnings outlook, we’ll now examine how these developments...
NasdaqGM:WLDN
NasdaqGM:WLDNProfessional Services

Should Willdan’s US$31 Million Wastewater Biogas Deal Reshape How WLDN Investors View Its Growth Path?

Willdan Group, Inc. recently announced it has been selected by Encina Wastewater Authority for a US$31,000,000 design-build contract to deliver a renewable cogeneration project that uses wastewater-derived biogas to produce on-site electricity and enhance plant resilience. This award highlights Willdan’s capabilities in integrating biogas conditioning, low-emission generation, emissions reduction upgrades, and battery storage with microgrid controls for complex infrastructure clients. We’ll...
NasdaqGS:STLD
NasdaqGS:STLDMetals and Mining

Did Pre‑Earnings Analyst Revisions Just Reframe Steel Dynamics' (STLD) Outlook and Investment Narrative?

In recent days, analysts revised their forecasts ahead of Steel Dynamics' now-completed earnings announcement, signaling that they anticipated meaningful updates on the company’s financial or operational outlook. This wave of pre-earnings estimate changes has drawn investor attention to how new information might reshape expectations for Steel Dynamics’ future performance. Next, we’ll examine how these pre-earnings analyst forecast revisions could influence Steel Dynamics’ investment...
NasdaqGS:WMT
NasdaqGS:WMTConsumer Retailing

Walmart (WMT) Adds Shirofune Tool To Make Connect Ad Campaigns Easier

Shirofune has launched an integration with Walmart Connect, allowing advertisers to manage Walmart campaigns within its platform. The integration is aimed at automating, centralizing, and optimizing retail media campaigns across Walmart and other digital channels. This development expands Walmart's retail media capabilities for brand partners using NasdaqGS:WMT's advertising network. Walmart, traded as NasdaqGS:WMT, is adding another tool to its retail media offering through Shirofune's new...
NYSE:SE
NYSE:SEMultiline Retail

Sea (SE) Faces Mixed Growth Signals, Is The Discount An Opportunity?

Sea (NYSE:SE) is back in focus after recent reports highlighted a sharp pullback in the stock, alongside strong forecasts for earnings and revenue growth, but softening analyst sentiment and a cautious Zacks ranking. See our latest analysis for Sea. Over the past year, Sea’s share price return has swung sharply, with recent weakness including a 1-day share price decline of 2.04% and a 7-day pullback of 6.38% following strong earnings expectations, insider sales under trading plans, and an...
NasdaqGS:VTRS
NasdaqGS:VTRSPharmaceuticals

Is Viatris (VTRS) Reframing Its Musculoskeletal Strategy Through the AAOS Pain Management Partnership?

Earlier this week, the American Academy of Orthopaedic Surgeons launched an online Pain Management Resource Center to support clinicians and patients across the full orthopaedic care pathway, developed with founding partners Curonix, Pacira BioSciences, Vertex Pharmaceuticals and Viatris. Viatris’ role as a founding partner in this comprehensive pain education initiative underscores its focus on supporting musculoskeletal pain care beyond its product portfolio. We’ll now examine how Viatris’...
NYSE:AXS
NYSE:AXSInsurance

Will AXIS Capital’s Earnings Surprise Momentum and Upbeat ESP Reading Change AXIS Capital Holdings' (AXS) Narrative

Recently, AXIS Capital Holdings’ strong track record of positive earnings surprises and a positive Zacks Earnings ESP of 3.82% highlighted rising analyst optimism ahead of its latest quarterly report. This pattern of earnings outperformance and upward estimate revisions has drawn attention to how consistently improving expectations can influence sentiment around the insurer’s near‑term performance. Next, we’ll examine how this positive earnings surprise momentum and analyst estimate...
NasdaqGS:NDSN
NasdaqGS:NDSNMachinery

Nordson (NDSN) Could Be 9% Undervalued Following Its AI And Electronics Growth Narrative

Recent performance context for Nordson stock Without a single defining news event, Nordson (NDSN) still offers plenty for investors to assess, from its recent share performance to the scale of its operations in industrial and medical dispensing systems. The stock is down about 1.5% over the past day and roughly flat over the past month, while gaining around 0.8% over the past week, 2.5% over the past 3 months, and 20% year to date. See our latest analysis for Nordson. At a share price of...
NasdaqGS:ZBRA
NasdaqGS:ZBRAElectronic

Zebra Technologies (ZBRA) Stock Looks Cheap On Cash Flow But Fair On Earnings

Zebra Technologies has delivered a share price that is still down sharply over five years, yet its Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside from current levels, while market multiples look closer to fair. The stock has declined 51.3% over the past five years, which sets a cautious backdrop for any case that it is now undervalued. Fresh product launches in high-speed machine vision can support long term growth expectations, but the valuation still faces...
NYSE:MTG
NYSE:MTGDiversified Financial

Is MGIC Investment (MTG) Fully Valued As Its Share Price Momentum Builds?

MGIC Investment (MTG) has drawn fresh attention after recent share price gains of 4.7% over the past week and 12.3% over the past month, prompting investors to reassess the mortgage insurer’s current valuation. See our latest analysis for MGIC Investment. Set against a 1 year total shareholder return of 19.58% and a 5 year total shareholder return of 143.64%, MGIC Investment’s recent share price strength suggests momentum has been building as investors reassess the balance between earnings,...
NasdaqGS:FCNC.A
NasdaqGS:FCNC.ABanks

Is First Citizens BancShares (FCNC.A) Cheap As Earnings Beat Hopes Build?

First Citizens BancShares (FCNC.A) is drawing attention as investors position ahead of its upcoming quarterly earnings report, with recent commentary highlighting a history of earnings surprises and a currently favorable Earnings ESP signal. See our latest analysis for First Citizens BancShares. First Citizens BancShares’ share price has edged higher over the past week and quarter, while the year to date share price return is slightly down and the 1 year total shareholder return is broadly...
NYSE:FN
NYSE:FNElectronic

Is Fabrinet (FN) Fully Priced After Its 419% 5 Year Run?

Fabrinet’s share price has delivered very strong 5 year gains, yet its valuation signals are pulling in different directions, with the intrinsic value estimate pointing to a premium while earnings based multiples suggest the stock screens as cheap. Fabrinet has returned 418.7% over 5 years, setting a high bar for what investors may expect from the stock at today’s price. Expectations for continued cash generation can support the current valuation, but any disappointment in future revenue or...